300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
Africa
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Morocco
Uruguay
Seychelles
Moldova
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Pei Kang

Managing Director @ Chengwei Capital

Shanghai, China

Pei Kang is a seed investor at Chengwei Capital in Shanghai focused on Medical and Genetics. Mr. Pei Kang serves as the Managing Director of Chengwei Capital. Mr. Kang joined Chengwei Capital in 2003. He serves as Board Observer of Polyera Corporation. He served as Senior Vice President of WK Technology Fund. He led WK's investment activities in China and made several investments in software and manufacturing sectors. Heserved as a Senior Executive at IBM for over 18 years. He served as General Manager of financial service sector in China at IBM. Mr. Kang has been a Director at Huaya Microelectronics, Inc. since December 6, 2004. He served as a Non Executive Director of AAC Technologies Holdings Inc. from February 15, 2007 to May 02, 2010. He holds BS from Chinese Culture University of Taiwan.

Total investments:
4
Last investment:
Lead investor:
50%

Last updated:

Industries Pei Kang invests in

MedicalGeneticsSoftwareBiopharmaAutomotive

Stages Pei Kang invests in

SeedAngelSeries ASeries C

Countries Pei Kang invests in

ChinaUnited States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 1 (25%)
  • Genetics 1 (25%)
  • Software 1 (25%)
  • Biopharma 1 (25%)
  • Automotive 1 (25%)
See all 10 industries →

Stage

  • Seed 1 (25%)
  • Angel 1 (25%)
  • Series A 1 (25%)
  • Series C 1 (25%)

Country

  • China 2 (50%)
  • United States 1 (25%)

Investments

CompanyDescriptionRoundLinks
Jushu Biotech is a medical engineering company that focuses on the research and development of synthetic biosensing technology. $13.9M / Seed / Nov 17, 2023
Jushu Biotech is a medical engineering company that focuses on the research and development of synthetic biosensing technology. $1.3M / Angel / Jan 13, 2023
Raythink is committed to the research and development of innovative applications of vehicle-mounted AR display products, providing customers with a highly reusable AR Generator ecological software platform, which enables the vehicle HMI system to continuously embed independent software algorithms/applications, and convert them into AR displaygraphics and visual effects. $15M / Series A / Jun 07, 2022
The Polyera Corporation is "a leading supplier in semiconductor, dielectric, and interfacial materials for the printed and flexible electronics industry. Polyera is focused on developing breakthrough materials for its portfolio of ActivInkâ„¢ products and on working closely with customers to provide deep technical support and customizedsolutions in order to enable the commercialization of novel printed and flexible electronic products." Series C / Apr 05, 2012

Co-Investors

Chengwei Capital

About Chengwei Capital

VC Fund · Shanghai, China

Chengwei Ventures is a venture capital firm.

Chengwei Capital Contacts

NameEmailPhoneSocials
Pei Kang Managing Director
Dong Chengxian Managing Director
Eric X Li
Eric X Li Founder, Managing Director
Lou Qun Managing Director
Ping Ping
Ping Ping Managing Director

Sign up to unlock verified contacts

Unlock Contacts

See all 7 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
Africa
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Morocco
Uruguay
Seychelles
Moldova
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Pei Kang invest in?

Pei Kang invests primarily in Medical, Genetics and Software startups, most often at Seed and Angel stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Pei Kang?

Public channels for Pei Kang include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Pei Kang last invest?

The most recent investment recorded for Pei Kang closed in Nov 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Pei Kang Find email